Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 May;125(5):876-88.
doi: 10.1542/peds.2009-2317. Epub 2010 Apr 12.

Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts

Affiliations
Comparative Study

Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts

Sebastian Schneeweiss et al. Pediatrics. 2010 May.

Abstract

Objective: The objective of this study was to assess the risk of suicide attempts and suicides after initiation of antidepressant medication use by children and adolescents, for individual agents.

Methods: We conducted a 9-year cohort study by using population-wide data from British Columbia. We identified new users of antidepressants who were 10 to 18 years of age with a recorded diagnosis of depression. Study outcomes were hospitalization attributable to intentional self-harm and suicide death.

Results: Of 20,906 children who initiated antidepressant therapy, 16,774 (80%) had no previous antidepressant use. During the first year of use, we observed 266 attempted and 3 completed suicides, which yielded an event rate of 27.04 suicidal acts per 1000 person-years (95% confidence interval [CI]: 23.9-30.5 suicidal acts per 1000 person-years). There were no meaningful differences in the rate ratios (RRs) comparing fluoxetine with citalopram (RR: 0.97 [95% CI: 0.54-1.76]), fluvoxamine (RR: 1.05 [95% CI: 0.46-2.43]), paroxetine (RR: 0.80 [95% CI: 0.47-1.37]), and sertraline (RR: 1.02 [95% CI: 0.56-1.84]). Tricyclic agents showed risks similar to those of selective serotonin reuptake inhibitors (RR: 0.92 [95% CI: 0.43-2.00]).

Conclusion: Our finding of equal event rates among antidepressant agents supports the decision of the Food and Drug Administration to include all antidepressants in the black box warning regarding potentially increased suicidality risk for children and adolescents beginning use of antidepressants.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Suicide and suicide attempt-free probability according to SSRI agent and time since treatment initiation. Because of the relatively low incidence of suicidal acts, the y-axis scale was inflated to allow for comparisons between agents.
FIGURE 2
FIGURE 2
Suicide and suicide attempt-free probability according to antidepressant class and time since treatment initiation. AD indicates antidepressant. Because of the relatively low incidence of suicidal acts, the y-axis scale was inflated to allow for comparisons between agents.

Comment in

References

    1. Food and Drug Administration Summary minutes of the September 13–14, 2004 Center for Drug Evaluation and Research Pharmachopharmacologic Drugs Advisory Committee and the FDA Pediatric Advisory Committee. [February 1, 2005]. Available at: www.fda.gov/ohrms/dockets/ac/04/minutes/2004-4065M1_Final.htm.
    1. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with anti-depressant drugs. Arch Gen Psychiatry. 2006;63(3):332–339. - PubMed
    1. Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry. 2006;63(12):1358–1367. - PubMed
    1. Didham RC, McConnell DW, Blair HJ, Reith DM. Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication. Br J Clin Pharmacol. 2005;60(5):519–525. - PMC - PubMed
    1. Olfson M, Marcus SC, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study. Arch Gen Psychiatry. 2006;63(8):865–872. - PubMed

Publication types

MeSH terms